dapsone has been researched along with Agranulocytosis in 54 studies
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone-induced agranulocytosis is a rare adverse effect." | 8.79 | Dapsone agranulocytosis in a leprosy patient. ( Hiran, S; Pande, TK; Pani, S; Vishwanathan, KA, 1994) |
| "Authors describe three cases of agranulocytosis in patients with giant cell (temporal) arterities treated with Dapsone and corticosteroids." | 8.77 | [Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature]. ( Bordessoule, D; Cransac, M; Fourgnaud-Gaillard, S; Liozon, E; Liozon, F; Rousset, H; Vidal, E; Weinbreck, P, 1988) |
| "Dapsone-induced agranulocytosis is a rare but potentially fatal adverse drug reaction (ADR)." | 7.85 | Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2. ( Božina, N; Čegec, I; Ganoci, L; Juričić Nahal, D; Likić, R; Potočnjak, I; Šimić, I, 2017) |
| "We describe a hitherto unreported laboratory observation, namely the selective preservation of basophils, in a case of severe dapsone-induced agranulocytosis." | 7.75 | Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. ( Beatty, C; Besser, M; Chitnavis, D; Clark, J; Vassiliou, G; Vera, J, 2009) |
| "Dapsone-induced agranulocytosis is a rare but potentially fatal adverse effect of treatment for tuberculoid leprosy." | 7.75 | Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications. ( De Silva, GV; Jayawardana, MA; Murugathas, S; Riyaaz, AA; Satarasinghe, RL; Wickrmasingha, UD; Wijesinghe, R, 2009) |
| "Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported." | 7.72 | A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient. ( Bhat, RM; Radhakrishnan, K, 2003) |
| "A patient with dermatitis herpetiformis was treated with dapsone." | 7.69 | [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis]. ( Callens, A; Gargot, S; Lorette, G; Machet, L; Mercier, E; Vaillant, L, 1996) |
| "During the 17-year period 1972 through 1988, a total of seven cases of agranulocytosis associated with the use of dapsone for the treatment of dermatitis herpetiformis were reported in Sweden." | 7.68 | The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. ( Hörnsten, P; Keisu, M; Wiholm, BE, 1990) |
| "A case of agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone) is described." | 7.67 | Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone). ( Barker, LC; Barton, CJ; Booth, F; Naik, RB, 1984) |
| "A case of dapsone-induced severe haemolytic anaemia and agranulocytosis is described." | 7.67 | Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity. ( Figueiredo, MS; Pinto, BO; Zago, MA, 1989) |
| "Dapsone has been suggested as a useful drug in the treatment of granuloma annulare; however, adverse reactions include a potentially life-threatening agranulocytosis." | 7.67 | Agranulocytosis caused by dapsone therapy for granuloma annulare. ( Kennedy, CT; Potter, MN; Slade, R; Yates, P, 1989) |
| "A case of agranulocytosis due to dapsone administered for the treatment of acne vulgaris is described." | 7.65 | Agranulocytosis due to dapsone. ( Firkin, FC; Mariani, AF, 1977) |
| "Agranulocytosis is a rare, severe and unpredictable idiosyncratic reaction associated with drug therapy that can lead to life-threatening illness." | 6.41 | Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. ( Coleman, MD, 2001) |
| "Dapsone-induced agranulocytosis is a rare adverse effect." | 4.79 | Dapsone agranulocytosis in a leprosy patient. ( Hiran, S; Pande, TK; Pani, S; Vishwanathan, KA, 1994) |
| "Authors describe three cases of agranulocytosis in patients with giant cell (temporal) arterities treated with Dapsone and corticosteroids." | 4.77 | [Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature]. ( Bordessoule, D; Cransac, M; Fourgnaud-Gaillard, S; Liozon, E; Liozon, F; Rousset, H; Vidal, E; Weinbreck, P, 1988) |
| "Dapsone is an extensively Used drug for the treatment of leprosy as well as'some other clinical problems worldwide: Its use has been predicted to increase further, especially in non leprosy conditions." | 3.83 | Dapsone: An Update. ( Aruna, B; Kallappa, H; Karjigi, S; Kusuma, MR; Murthy, SC; Reddy, YN, 2016) |
| "We describe a hitherto unreported laboratory observation, namely the selective preservation of basophils, in a case of severe dapsone-induced agranulocytosis." | 3.75 | Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases. ( Beatty, C; Besser, M; Chitnavis, D; Clark, J; Vassiliou, G; Vera, J, 2009) |
| "Multidrug therapy (WHO/MDT) in multibacillary leprosy consists of treatment with rifampicin, dapsone and clofazimine." | 3.75 | Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report. ( Guedes Filho, G; Guedes, WR; Oliveira, BB; Oliveira, CA; Oliveira, DA; Silva, IM, 2009) |
| "Dapsone-induced agranulocytosis is a rare but potentially fatal adverse effect of treatment for tuberculoid leprosy." | 3.75 | Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications. ( De Silva, GV; Jayawardana, MA; Murugathas, S; Riyaaz, AA; Satarasinghe, RL; Wickrmasingha, UD; Wijesinghe, R, 2009) |
| "Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported." | 3.72 | A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient. ( Bhat, RM; Radhakrishnan, K, 2003) |
| "A patient with dermatitis herpetiformis was treated with dapsone." | 3.69 | [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis]. ( Callens, A; Gargot, S; Lorette, G; Machet, L; Mercier, E; Vaillant, L, 1996) |
| "During the 17-year period 1972 through 1988, a total of seven cases of agranulocytosis associated with the use of dapsone for the treatment of dermatitis herpetiformis were reported in Sweden." | 3.68 | The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. ( Hörnsten, P; Keisu, M; Wiholm, BE, 1990) |
| "A case of dapsone-induced severe haemolytic anaemia and agranulocytosis is described." | 3.67 | Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity. ( Figueiredo, MS; Pinto, BO; Zago, MA, 1989) |
| "Dapsone has been suggested as a useful drug in the treatment of granuloma annulare; however, adverse reactions include a potentially life-threatening agranulocytosis." | 3.67 | Agranulocytosis caused by dapsone therapy for granuloma annulare. ( Kennedy, CT; Potter, MN; Slade, R; Yates, P, 1989) |
| "Agranulocytosis is a rare, severe and unpredictable idiosyncratic reaction associated with drug therapy that can lead to life-threatening illness." | 2.41 | Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. ( Coleman, MD, 2001) |
| "1." | 2.39 | Dapsone toxicity: some current perspectives. ( Coleman, MD, 1995) |
| "Drug-induced agranulocytosis (DIA) is a potentially fatal disorder." | 1.31 | Hematopoietic growth factors in drug-induced agranulocytosis. ( Pavithran, K; Thomas, M, 2002) |
| "Drug induced agranulocytosis is a rare condition." | 1.31 | Agranulocytosis--a case report. ( Chowdhury, SA; Rahman, J; Wajed, J, 2000) |
| "Twenty-one cases of agranulocytosis following dosage with one tablet of Maloprim given once or twice weekly are reviewed." | 1.27 | Agranulocytosis associated with maloprim: review of cases. ( Farquhar, JA; Hutchinson, DB; Whiteman, PD, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (55.56) | 18.7374 |
| 1990's | 9 (16.67) | 18.2507 |
| 2000's | 9 (16.67) | 29.6817 |
| 2010's | 4 (7.41) | 24.3611 |
| 2020's | 2 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bartakke, SP | 1 |
| Sampagar, AA | 1 |
| Reddy, NA | 1 |
| Kangle, R | 1 |
| St Claire, K | 1 |
| Kaul, S | 1 |
| Caldito, EG | 1 |
| Kramer, ON | 1 |
| Griffin, T | 1 |
| Albrecht, J | 1 |
| Potočnjak, I | 1 |
| Likić, R | 1 |
| Šimić, I | 1 |
| Juričić Nahal, D | 1 |
| Čegec, I | 1 |
| Ganoci, L | 1 |
| Božina, N | 1 |
| Karjigi, S | 1 |
| Murthy, SC | 1 |
| Kallappa, H | 1 |
| Kusuma, MR | 1 |
| Aruna, B | 1 |
| Reddy, YN | 1 |
| Milkova, L | 1 |
| Hallermann, C | 1 |
| Simon, JC | 1 |
| Treudler, R | 1 |
| Besser, M | 1 |
| Vera, J | 1 |
| Clark, J | 1 |
| Chitnavis, D | 1 |
| Beatty, C | 1 |
| Vassiliou, G | 1 |
| Ranawaka, RR | 1 |
| Mendis, S | 1 |
| Weerakoon, HS | 1 |
| Silva, IM | 1 |
| Oliveira, CA | 1 |
| Guedes, WR | 1 |
| Oliveira, BB | 1 |
| Oliveira, DA | 1 |
| Guedes Filho, G | 1 |
| Satarasinghe, RL | 1 |
| Jayawardana, MA | 1 |
| De Silva, GV | 1 |
| Murugathas, S | 1 |
| Riyaaz, AA | 1 |
| Wickrmasingha, UD | 1 |
| Wijesinghe, R | 1 |
| Piette, EW | 1 |
| Werth, VP | 1 |
| Pavithran, K | 1 |
| Thomas, M | 1 |
| Bhat, RM | 1 |
| Radhakrishnan, K | 1 |
| Hoffmann, TK | 1 |
| von Schmiedeberg, S | 1 |
| Wulferink, M | 1 |
| Thier, R | 1 |
| Bier, H | 1 |
| Ruzicka, T | 1 |
| Lehmann, P | 1 |
| McConkey, B | 1 |
| Revuz, J | 1 |
| Hornac, P | 1 |
| Rée, GH | 1 |
| Friman, G | 1 |
| Nyström-Rosander, C | 1 |
| Jonsell, G | 1 |
| Björkman, A | 1 |
| Lekås, G | 1 |
| Svendsrup, B | 1 |
| Bruce-Chwatt, LJ | 1 |
| Hutchinson, DB | 2 |
| Booth, F | 1 |
| Barker, LC | 1 |
| Barton, CJ | 1 |
| Naik, RB | 1 |
| Vergara, RV | 1 |
| Miyagawa, S | 1 |
| Shiomi, Y | 1 |
| Fukumoto, T | 1 |
| Ishii, Y | 1 |
| Shirai, T | 1 |
| Coleman, MD | 3 |
| Simpson, J | 1 |
| Jacobus, DP | 1 |
| Cockburn, EM | 1 |
| Wood, SM | 1 |
| Waller, PC | 1 |
| Bleehen, SS | 1 |
| Woodbury, GR | 1 |
| Fried, W | 1 |
| Ertle, JO | 1 |
| Malkinson, FD | 1 |
| Machet, L | 1 |
| Callens, A | 1 |
| Mercier, E | 1 |
| Gargot, S | 1 |
| Lorette, G | 1 |
| Vaillant, L | 1 |
| Hiran, S | 1 |
| Pande, TK | 1 |
| Pani, S | 1 |
| Vishwanathan, KA | 1 |
| Rahman, J | 1 |
| Chowdhury, SA | 1 |
| Wajed, J | 1 |
| Lang, PG | 1 |
| Wilson, JR | 1 |
| Harris, JW | 1 |
| Firkin, FC | 1 |
| Mariani, AF | 1 |
| Graham, WR | 1 |
| Reeve, P | 1 |
| Hörnsten, P | 1 |
| Keisu, M | 1 |
| Wiholm, BE | 1 |
| Figueiredo, MS | 1 |
| Pinto, BO | 1 |
| Zago, MA | 1 |
| Potter, MN | 1 |
| Yates, P | 1 |
| Slade, R | 1 |
| Kennedy, CT | 1 |
| Eulry, F | 1 |
| Pattin, S | 1 |
| Auzanneau, G | 1 |
| Martoia, R | 1 |
| Doury, P | 1 |
| Demaziere, A | 1 |
| Liozon, F | 1 |
| Fourgnaud-Gaillard, S | 1 |
| Bordessoule, D | 1 |
| Rousset, H | 1 |
| Vidal, E | 1 |
| Weinbreck, P | 1 |
| Liozon, E | 1 |
| Cransac, M | 1 |
| Barss, P | 1 |
| Whiteman, PD | 1 |
| Farquhar, JA | 1 |
| Lahuerta-Palacios, JJ | 1 |
| Gomez-Pedraja, JF | 1 |
| Montalban, MA | 1 |
| Shandas, GJ | 1 |
| Gomez-Salazar, MD | 1 |
| Ten Broeke, JE | 1 |
| Cunningham, LD | 1 |
| Jopling, WH | 1 |
| Catalano, PM | 1 |
| Ognibene, AJ | 2 |
| Stickland, JF | 1 |
| Hurdle, AD | 1 |
| Bernstein, G | 1 |
| Smithurst, BA | 1 |
| Robertson, I | 1 |
| Naughton, MA | 1 |
| Levine, PH | 1 |
| Weintraub, LW | 1 |
7 reviews available for dapsone and Agranulocytosis
| Article | Year |
|---|---|
Dapsone in the management of autoimmune bullous diseases.
Topics: Agranulocytosis; Animals; Autoimmune Diseases; Dapsone; Disease Management; Drug Hypersensitivity; H | 2012 |
[Side effects of treatment with sulfones].
Topics: Adult; Agranulocytosis; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Eruptions; Drug | 1981 |
Dapsone toxicity: some current perspectives.
Topics: Agranulocytosis; Anti-Infective Agents; Dapsone; Humans; Liver; Methemoglobinemia | 1995 |
Dapsone agranulocytosis in a leprosy patient.
Topics: Adult; Agranulocytosis; Dapsone; Female; Humans; Leprostatic Agents; Leprosy | 1994 |
Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
Topics: Agranulocytosis; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Daps | 2001 |
Adverse effects of dapsone.
Topics: Agranulocytosis; Anemia, Hemolytic; Dapsone; Erythrocytes; Humans; Leukocytes; Leukopenia; Methemogl | 1975 |
[Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature].
Topics: Aged; Aged, 80 and over; Agranulocytosis; Dapsone; Female; Giant Cell Arteritis; Humans | 1988 |
47 other studies available for dapsone and Agranulocytosis
| Article | Year |
|---|---|
Dapsone Induced Agranulocytosis and Hemolytic Anemia in Immune Thrombocytopenic Purpura.
Topics: Agranulocytosis; Anemia, Hemolytic; Dapsone; Humans; Purpura; Purpura, Thrombocytopenic; Purpura, Th | 2020 |
Dapsone-induced agranulocytosis: symptoms may alert more reliably than the current blood monitoring protocol.
Topics: Agranulocytosis; Dapsone; Humans | 2021 |
Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
Topics: Agranulocytosis; Anti-Infective Agents; Arylamine N-Acetyltransferase; Dapsone; Enzyme Activation; H | 2017 |
Dapsone: An Update.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy; Methe | 2016 |
Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria.
Topics: Aged; Agranulocytosis; Chronic Disease; Dapsone; Dose-Response Relationship, Drug; Granulocyte Colon | 2014 |
Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases.
Topics: Adult; Agranulocytosis; Basophils; Dapsone; Female; Humans; Leukocytes; Lupus Erythematosus, Discoid | 2009 |
Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Glucosep | 2008 |
Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; | 2009 |
Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
Topics: Adult; Agranulocytosis; Dapsone; Fatal Outcome; Female; Humans; Leprostatic Agents; Leprosy, Tubercu | 2009 |
Hematopoietic growth factors in drug-induced agranulocytosis.
Topics: Adolescent; Adult; Agranulocytosis; Chlorpromazine; Dapsone; Dipyrone; Female; Granulocyte-Macrophag | 2002 |
A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
Topics: Agranulocytosis; Dapsone; Fatal Outcome; Humans; Leprosy, Borderline; Male; Middle Aged | 2003 |
[Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].
Topics: Adult; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Arylamine N-Acetyltransferase; Daps | 2005 |
Adverse reactions to dapsone.
Topics: Adult; Agranulocytosis; Arthritis, Rheumatoid; Child; Dapsone; Humans | 1981 |
Reactions to dapsone.
Topics: Agranulocytosis; Dapsone; Drug Combinations; Humans; Malaria; Medication Errors; Pyrimethamine | 1981 |
Chemoprophylaxis of malaria in Africa.
Topics: Agranulocytosis; Antimalarials; Dapsone; Drug Combinations; Humans; Malaria; Male; Middle Aged; Pyri | 1983 |
Agranulocytosis associated with malaria prophylaxis with Maloprim.
Topics: Adult; Aged; Agranulocytosis; Antimalarials; Dapsone; Drug Combinations; Female; Humans; Malaria; Ma | 1983 |
Agranulocytosis associated with Maloprim.
Topics: Aged; Agranulocytosis; Dapsone; Drug Combinations; Female; Humans; Malaria; Middle Aged; Pyrimethami | 1983 |
Agranulocytosis associated with Maloprim.
Topics: Agranulocytosis; Antimalarials; Dapsone; Drug Combinations; Humans; Male; Pyrimethamine | 1984 |
Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
Topics: Agranulocytosis; Antimalarials; Dapsone; Drug Combinations; Humans; Male; Middle Aged; Pyrimethamine | 1984 |
Maloprim--general toxicity or idiosyncrasy?
Topics: Adult; Agranulocytosis; Dapsone; Drug Combinations; Female; Humans; Malaria; Pyrimethamine | 1984 |
Recombinant granulocyte colony-stimulating factor for dapsone-induced agranulocytosis in leukocytoclastic vasculitis.
Topics: Adolescent; Agranulocytosis; Dapsone; Female; Granulocyte Colony-Stimulating Factor; Humans; Recombi | 1993 |
Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
Topics: Agranulocytosis; Cell Death; Dapsone; Diabetes Mellitus; Ditiocarb; Erythrocytes; Humans; Leukocytes | 1994 |
Dapsone-induced agranulocytosis: spontaneous reporting data.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Agranulocytosis | 1993 |
Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis.
Topics: Agranulocytosis; Anemia; Dapsone; Female; Humans; Middle Aged; Vasculitis, Leukocytoclastic, Cutaneo | 1993 |
[Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
Topics: Agranulocytosis; Dapsone; Dermatitis Herpetiformis; Fever; Humans; Male; Middle Aged | 1996 |
Agranulocytosis--a case report.
Topics: Adult; Agranulocytosis; Anti-Infective Agents; Dapsone; Female; Humans | 2000 |
Sulfones and sulfonamides in dermatology today.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity; Hemolysis; Humans; Kidney Diseases; Methemoglobinem | 1979 |
Hematologic side-effects of dapsone.
Topics: Adult; Agranulocytosis; Dapsone; Female; Hematologic Diseases; Hematopoietic System; Hemolysis; Huma | 1977 |
Agranulocytosis due to dapsone.
Topics: Adult; Agranulocytosis; Dapsone; Female; Humans | 1977 |
Agranulocytosis during multidrug therapy (MDT) of leprosy.
Topics: Adult; Agranulocytosis; Dapsone; Female; Humans; Leprosy | 1992 |
The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Dapsone; Dermatitis Herpetiformis; Female; Humans; | 1990 |
Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity.
Topics: Aged; Agranulocytosis; Anemia, Hemolytic; Dapsone; Female; Glucosephosphate Dehydrogenase; Humans | 1989 |
Agranulocytosis caused by dapsone therapy for granuloma annulare.
Topics: Agranulocytosis; Dapsone; Elbow; Escherichia coli Infections; Female; Granuloma; Humans; Knee; Middl | 1989 |
[Agranulocytosis caused by dapsone in rheumatoid arthritis].
Topics: Aged; Agranulocytosis; Arthritis, Rheumatoid; Dapsone; Female; Humans | 1989 |
Dapsone in the long-term treatment of temporal arteritis.
Topics: Agranulocytosis; Dapsone; Giant Cell Arteritis; Humans | 1989 |
Fatal dapsone agranulocytosis in a Melanesian.
Topics: Adult; Agranulocytosis; Dapsone; Humans; Male; Pneumonia; Pseudomonas Infections | 1986 |
Agranulocytosis associated with maloprim: review of cases.
Topics: Adult; Agranulocytosis; Antimalarials; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; | 1986 |
Proliferation of IgD kappa plasma cells after agranulocytosis induced by dapsone.
Topics: Agranulocytosis; Bone Marrow; Dapsone; Dermatitis Herpetiformis; Humans; Hypergammaglobulinemia; Imm | 1985 |
Agranulocytosis during dapsone administration.
Topics: Aged; Agranulocytosis; Dapsone; Dermatitis Herpetiformis; Humans; Male | 1973 |
Why agranulocytosis from dapsone?
Topics: Agranulocytosis; Dapsone; Humans; Leprosy; Military Medicine; United States; Vietnam | 1972 |
Dapsone agranulocytosis.
Topics: Agranulocytosis; Antimalarials; Dapsone; Drug Synergism; Humans; Male; Military Medicine; Probenecid | 1971 |
Emerging medical problems in Vietnam.
Topics: Agranulocytosis; Dapsone; Dysentery, Amebic; Enterobacteriaceae Infections; Humans; Liver Abscess, A | 1970 |
Agranulocytosis probably due to dapsone in an infantry soldier.
Topics: Adult; Agranulocytosis; Australia; Dapsone; Humans; Malaria; Male; Military Personnel; Pseudomonas I | 1970 |
Agranulocytosis due to dapsone.
Topics: Adult; Agranulocytosis; Dapsone; Humans; Malaria; Male; Military Medicine; Time Factors; Tropical Me | 1970 |
Sulfones.
Topics: Agranulocytosis; Dapsone; Humans | 1970 |
Dapsone-induced agranulocytosis complicated by gram-negative septicaemia.
Topics: Adult; Agranulocytosis; Australia; Dapsone; Humans; Male; Military Medicine; Military Personnel; Sep | 1971 |
Pseudoleukemia during recovery from dapsone-induced agranulocytosis.
Topics: Adult; Agranulocytosis; Blood Cell Count; Blood Platelets; Bone Marrow Cells; Dapsone; Diagnosis, Di | 1968 |